Masahiro Sakagami1, Hua Li2, Jügen Venitz2. 1. Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University (VCU), 410 N 12th Street, P.O. Box 980533, Richmond, Virginia, 23298-0533, USA. msakagam@vcu.edu. 2. Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University (VCU), 410 N 12th Street, P.O. Box 980533, Richmond, Virginia, 23298-0533, USA.
Abstract
PURPOSE: To establish an in vivo-relevant Transwell dish-based dissolution test system for the "respirable" aerosols of inhaled corticosteroids (ICSs) using marketed inhaler products. METHODS: "Respirable" ≤ 5.8 or 6.5 μm aerosols of 7 ICSs from 11 inhaler products were collected onto the filter membranes under the modified assembly of the cascade impactor. Their dissolution in 10 ml of the simulated lung lining fluid (sLLF) was determined over time in the Transwell dish at 37°C and ~100% relative humidity in the presence of subsequent diffusive permeation across the Transwell's supporting membrane. RESULTS: While three ICSs with high-to-intermediate solubility enabled the first-order "sink" and complete dissolution in 6 h, 4 ICSs with poor solubility including fluticasone propionate (FP) resulted in the pseudo-zero-order "non-sink", slow and limited dissolution. The aerosol dissolution rate constants (kdiss) were derived, well-correlated with the solubility. For FP, but not for highly-soluble flunisolide (FN), dissolution was kinetically aerosol mass-dependent. However, for a given ICS, dissolution profiles were indistinguishable between the formulations and products upon comparable aerosol mass collection. CONCLUSIONS: The in vivo-relevant Transwell dish-based "respirable" aerosol dissolution test system was developed, kinetically discriminative in accordance with the ICS solubility, but indistinguishable for a given ICS between the marketed products.
PURPOSE: To establish an in vivo-relevant Transwell dish-based dissolution test system for the "respirable" aerosols of inhaled corticosteroids (ICSs) using marketed inhaler products. METHODS: "Respirable" ≤ 5.8 or 6.5 μm aerosols of 7 ICSs from 11 inhaler products were collected onto the filter membranes under the modified assembly of the cascade impactor. Their dissolution in 10 ml of the simulated lung lining fluid (sLLF) was determined over time in the Transwell dish at 37°C and ~100% relative humidity in the presence of subsequent diffusive permeation across the Transwell's supporting membrane. RESULTS: While three ICSs with high-to-intermediate solubility enabled the first-order "sink" and complete dissolution in 6 h, 4 ICSs with poor solubility including fluticasone propionate (FP) resulted in the pseudo-zero-order "non-sink", slow and limited dissolution. The aerosol dissolution rate constants (kdiss) were derived, well-correlated with the solubility. For FP, but not for highly-soluble flunisolide (FN), dissolution was kinetically aerosol mass-dependent. However, for a given ICS, dissolution profiles were indistinguishable between the formulations and products upon comparable aerosol mass collection. CONCLUSIONS: The in vivo-relevant Transwell dish-based "respirable" aerosol dissolution test system was developed, kinetically discriminative in accordance with the ICS solubility, but indistinguishable for a given ICS between the marketed products.
Authors: Wallace P Adams; Richard C Ahrens; Mei-Ling Chen; David Christopher; Badrul A Chowdhury; Dale P Conner; Richard Dalby; Kevin Fitzgerald; Leslie Hendeles; Anthony J Hickey; Günther Hochhaus; Beth L Laube; Paul Lucas; Sau L Lee; Svetlana Lyapustina; Bing Li; Dennis O'Connor; Neil Parikh; David A Parkins; Prasad Peri; Gary R Pitcairn; Michael Riebe; Partha Roy; Tushar Shah; Gur Jai Pal Singh; Sandra Suarez Sharp; Julie D Suman; Marjolein Weda; Janet Woodcock; Lawrence Yu Journal: J Aerosol Med Pulm Drug Deliv Date: 2010-02 Impact factor: 2.849
Authors: Dennis O'Connor; Wallace P Adams; Mei-Ling Chen; Peter Daley-Yates; John Davis; Hartmut Derendorf; Murray P Ducharme; Anders Fuglsang; Myra Herrle; Günther Hochhaus; Susan M Holmes; Sau L Lee; Bing V Li; Svetlana Lyapustina; Stephen Newman; Martin Oliver; Beverley Patterson; Joanne Peart; Guirag Poochikian; Partha Roy; Tushar Shah; Gur Jai Pal Singh; Sandra Suarez Sharp Journal: J Aerosol Med Pulm Drug Deliv Date: 2011-03-31 Impact factor: 2.849
Authors: Dongmei Lu; Sau L Lee; Robert A Lionberger; Stephanie Choi; Wallace Adams; Hoainhon N Caramenico; Badrul A Chowdhury; Dale P Conner; Rohit Katial; Susan Limb; John R Peters; Lawrence Yu; Sally Seymour; Bing V Li Journal: AAPS J Date: 2015-03-11 Impact factor: 4.009
Authors: Gabriela Apiou-Sbirlea; Steve Newman; John Fleming; Ruediger Siekmeier; Stephan Ehrmann; Gerhard Scheuch; Guenther Hochhaus; Anthony Hickey Journal: Ther Deliv Date: 2013-03